Monday, September 19, 2016 12:04:47 PM
On September 12, 2016, pursuant to Article III of our Articles of Incorporation, our Board of Directors voted to designate a class of preferred stock entitled Series B Preferred Stock, consisting of up to nine million seven hundred and fifty thousand (9,750,000) shares, par value $0.001. Under the Certificate of Designation, holders of Series B Preferred Stock will shall be entitled to distributions made on a liquidation of the company on a pari passu basis with the holders our common stock and Series A Preferred Stock at a stated value of $1.00 per share. The holders are also entitled to vote together with the holders of our common stock and Series A Preferred Stock on all matters submitted to shareholders at a rate of one (1) vote for each share held. The holders are further entitled to convert each share of their Series B Preferred Stock into shares of common stock at a conversion rate of the closing price of our common stock one day following the demand for conversion, provided that there shall be a floor price of $1.00 per share and a ceiling price of $2.00 per share.
Market Value1 $13,174,211 a/o Sep 16, 2016
Authorized Shares 250,000,000 a/o Aug 10, 2015
Outstanding Shares 5,803,617 a/o Apr 20, 2016
You can lead a horse to water. But you can't make him get down on one knee and do an Al Jolson impression!
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM